V-PYRRO/NO: AN HEPATO-SELECTIVE NITRIC OXIDE DONOR IMPROVES PORCINE LIVER HEMODYNAMICS AND FUNCTION AFTER ISCHEMIA REPERFUSION1-Reference-Cited by-同舟云学术

V-PYRRO/NO: AN HEPATO-SELECTIVE NITRIC OXIDE DONOR IMPROVES PORCINE LIVER HEMODYNAMICS AND FUNCTION AFTER ISCHEMIA REPERFUSION1

Published:2001-01 Issue:2 Volume:71 Page:193-198
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Ricciardi Rocco,Foley David P.,Quarfordt Steven H.,Saavedra Joseph E.,Keefer Larry K.,Wheeler Suzanne M.,Donohue Susan E.,Callery Mark P.,Meyers William C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference27 articles.

1. SINUSOIDAL LINING CELL DAMAGE

2. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers

3. Extended preservation and effect of nitric oxide production in liver transplantation

4. Nitric Oxide: Pathophysiological Mechanisms

5. BENEFICIAL EFFECTS OF FK409, A NOVEL NITRIC OXIDE DONOR, ON REPERFUSION INJURY OF RAT LIVER

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term treatment with hepatoselective NO donor V-PYRRO/NO improves blood flow in hepatic microcirculation in liver steatosis in mice;Pharmacological Reports;2018-06

2. Differential effects of liver steatosis on pharmacokinetic profile of two closely related hepatoselective NO-donors; V-PYRRO/NO and V-PROLI/NO;Pharmacological Reports;2017-06

3. Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver;Pharmacological Reports;2015-08

4. Nitric oxide in liver diseases;Trends in Pharmacological Sciences;2015-08

5. Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics;Drug Metabolism and Disposition;2015-04-13